L26/P-864 clinical effectiveness of hyaluronan-enriched embryo transfer medium assessed using statistical and machine learning approaches
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1188 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Z. Klawikowska und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does hyaluronan-enriched embryo transfer medium improve clinical pregnancy rates in in vitro fertilization (IVF), and can benefiting patient subgroups be identified? Summary answer Hyaluronan-enriched embryo transfer medium did not improve clinical pregnancy rates, and neither statistical nor machine learning analyses identified patient subgroups benefiting from its use. What is known already Implantation remains a major limiting step for treatment success in IVF, requiring a precisely timed interaction between a competent embryo and a receptive endometrium, and may fail even after transfer of morphologically high-quality embryos due to its multifactorial nature. Hyaluronan, naturally present in the female reproductive tract and increased during the window of implantation, provides a biological rationale for hyaluronan-enriched embryo transfer media. However, published evidence regarding their clinical effectiveness remains inconsistent, and patient groups that may benefit have not been clearly identified; consequently, routine use remains controversial. Study design, size, duration Retrospective observational cohort study of 12363 IVF embryo transfer cycles performed between 2017 and 2025. Hyaluronan-enriched transfer medium (EmbryoGlue) was used in 3097 cycles (25%); 4713 cycles (38%) fulfilled predefined clinical indications for its use. The primary endpoint was clinical pregnancy. Comparative analyses were performed in the overall cohort and within the indicated subgroup. Participants/materials, setting, methods IVF embryo transfer cycles were retrospectively analyzed. Clinical indications for hyaluronan-enriched transfer medium included recurrent miscarriage (≥2 losses), repeated implantation failure, or maternal age >37 years. Clinical pregnancy was defined as ultrasound confirmation of at least one gestational sac. Associations between EmbryoGlue use and clinical pregnancy were assessed using univariable tests, multivariable logistic regression with interaction terms, and non-linear machine learning models with shapley additive explanations (SHAP)-based interpretability. Main results and the role of chance In the overall cohort, use of hyaluronan-enriched transfer medium was not associated with higher clinical pregnancy rates. Clinical pregnancy occurred in 44.2% of cycles with EmbryoGlue and 46.6% without it. Although a univariable comparison showed a statistically significant association (χ² test, p = 0.023), the absolute difference was small and unfavorable for EmbryoGlue, suggesting confounding by indication. When the analysis was restricted to patients fulfilling predefined clinical indications for EmbryoGlue, no difference in clinical pregnancy rates was observed between cycles with and without its use (28.5% vs 29.3%; p = 0.65). Multivariable logistic regression adjusting for demographic, clinical, and embryological covariates showed no effect of EmbryoGlue on clinical pregnancy, either as a main effect or through interaction with ovulatory disorders (adjusted OR≈1). Non-linear machine learning models, including a histogram-based gradient boosting classifier, demonstrated consistent findings, with EmbryoGlue exhibiting minimal predictive importance based on SHAP values, while patient age, embryo quality, BMI, anti-Müllerian hormone (AMH), and semen parameters dominated outcome prediction. These convergent results indicate that observed differences are unlikely to reflect a causal effect of EmbryoGlue and are better explained by underlying patient and treatment characteristics. Limitations, reasons for caution This study was retrospective and observational, limiting causal inference. Use of EmbryoGlue was not randomized and may reflect residual confounding despite multivariable adjustment. Some subgroup analyses were limited by sample size. Live birth and long-term offspring outcomes were not assessed. Wider implications of the findings These findings do not support routine use of hyaluronan-enriched transfer media to improve clinical pregnancy rates in IVF. Clinical decision-making should prioritize established prognostic factors over adjunctive embryo transfer additives, and future research should focus on interventions with demonstrable clinical benefit. Trial registration number No
Zitieren
APA
Klawikowska, Z., & Drabczyk, D. (2026). L26/P-864 clinical effectiveness of hyaluronan-enriched embryo transfer medium assessed using statistical and machine learning approaches. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1188
Vancouver
Klawikowska Z, Drabczyk D. L26/P-864 clinical effectiveness of hyaluronan-enriched embryo transfer medium assessed using statistical and machine learning approaches. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1188
BibTeX
@article{Klawikowska2026,
author = {Klawikowska, Z. and Drabczyk, D.},
title = {L26/P-864 clinical effectiveness of hyaluronan-enriched embryo transfer medium assessed using statistical and machine learning approaches},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1188}
}
EUVIMED